Britain nears 500 million stg deal for Sanofi/GSK Covid-19 vaccine
Sanofi is working on two possible Covid-19 vaccines, one of which uses an adjuvant made by GSK to potentially boost its efficacy
Sanofi is working on two possible Covid-19 vaccines, one of which uses an adjuvant made by GSK to potentially boost its efficacy